Login
$SLS
$12.12 +$0.78 (6.88%) Live

Ownership

13F as of Q2 2026 · 201.9M shares outstanding

Who owns SLS?

By type of holder
Institutions 35.5% Insiders 1.7% Everyone else 62.8%
Concentration Top 10 holders own 27.1%
BlackRock, Inc. 7.5% · State Street Corp 6.4%
Institutional ownership
35.5%
+8.8 pts vs last qtr
Institutional holders
192
+34 vs last qtr
Net shares bought
+17.8M
by institutions in Q2 2026
New / sold out
64 / 30
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • State Street Corp +4.6M
  • Anson Funds Management LP NEW +4.5M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Marshall Wace, LLP SOLD OUT −2.0M
  • Two Sigma Investments, LP SOLD OUT −403.2K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Sellas Life Sciences Group Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2025
+78.2%
+78.18% a year
Each share's claim on the business
−43.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $3.52M
over 2 fiscal years
Diluted shares, split-adjusted
59.4M84.8M110.1M2024: 61.2M shares'242025: 109.1M shares'25
Buybacks Stock-based comp
$0$978.0K$2.0M2024 buybacks: $02024 stock comp: $1.6M'242025 buybacks: $02025 stock comp: $2.0M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years67% 3–5 years1% 1–3 years14% Under 1 year17%
Quarterly turnover
26.5%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting SLS on Form 13F
B
BlackRock, Inc.
Shares
15.1M
% of company
7.46%
Change vs last qtr
+2.9M (+23.5%)
Held since
≤2021
SS
State Street Corp
Shares
13.0M
% of company
6.44%
Change vs last qtr
+4.6M (+54.8%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Sellas Life Sciences Group Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting SLS on Form N-PORT; together they hold 17.4% of the company
Position value
$128M
% of company
4.29%
% of the fund
1.19%
As of
June 30, 2026
VT
Position value
$87.2M
% of company
2.93%
% of the fund
0.00%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Sellas Life Sciences Group Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
SA
Stergiou Andelos M.
Insider
Shares
1.8M
% of company
0.87%
Change vs last qtr
—
Held since
—
CD
Cicic Dragan
Insider
Shares
557.8K
% of company
0.28%
Change vs last qtr
—
Held since
—

6 more holders behind a free account

See every insider and 5%+ holder of Sellas Life Sciences Group Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support